EP1140976A4 - Proteines secretees et leurs utilisations - Google Patents

Proteines secretees et leurs utilisations

Info

Publication number
EP1140976A4
EP1140976A4 EP99967734A EP99967734A EP1140976A4 EP 1140976 A4 EP1140976 A4 EP 1140976A4 EP 99967734 A EP99967734 A EP 99967734A EP 99967734 A EP99967734 A EP 99967734A EP 1140976 A4 EP1140976 A4 EP 1140976A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
secreted
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99967734A
Other languages
German (de)
English (en)
Other versions
EP1140976A2 (fr
Inventor
Thomas M Barnes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of EP1140976A2 publication Critical patent/EP1140976A2/fr
Publication of EP1140976A4 publication Critical patent/EP1140976A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99967734A 1998-12-30 1999-12-29 Proteines secretees et leurs utilisations Withdrawn EP1140976A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22424698A 1998-12-30 1998-12-30
US224246 1998-12-30
PCT/US1999/031157 WO2000039149A2 (fr) 1998-12-30 1999-12-29 Proteines secretees et leurs utilisations

Publications (2)

Publication Number Publication Date
EP1140976A2 EP1140976A2 (fr) 2001-10-10
EP1140976A4 true EP1140976A4 (fr) 2003-05-21

Family

ID=22839862

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99967734A Withdrawn EP1140976A4 (fr) 1998-12-30 1999-12-29 Proteines secretees et leurs utilisations

Country Status (3)

Country Link
EP (1) EP1140976A4 (fr)
AU (1) AU2396600A (fr)
WO (1) WO2000039149A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030099947A1 (en) 1998-09-21 2003-05-29 Bazan J. Fernando Mammalian cytokines; related reagents and methods
JP4454859B2 (ja) 1998-11-13 2010-04-21 イミュネックス・コーポレーション ヒトｔｓｌｐｄｎａおよびポリペプチド
WO2003032898A2 (fr) 2001-07-23 2003-04-24 Immunex Corporation Lymphopoietine thymique stromale (tslp) humaine modifiee
AUPR670701A0 (en) * 2001-07-30 2001-08-23 Prince Henry's Institute Of Medical Research Novel serine protease
AU2003280642A1 (en) * 2002-11-01 2004-05-25 Takeda Pharmaceutical Company Limited Apoptosis inducer
DE102004004924B4 (de) * 2004-01-27 2007-04-26 Eberhard-Karls-Universität Tübingen Universitätsklinikum A141S-und G399S-Mutation im Omi/HtrA2-Protein bei Morbus Parkinson
UA95329C2 (ru) 2006-12-14 2011-07-25 Шеринг-Плау Лтд. Собачий тимусный стромальный лимфопоэтин и его применение
BRPI0720271A2 (pt) 2006-12-14 2014-01-28 Schering Corp Anticorpo anti-tslp projetado
US7982016B2 (en) 2007-09-10 2011-07-19 Amgen Inc. Antigen binding proteins capable of binding thymic stromal lymphopoietin
CN114835812A (zh) 2008-12-09 2022-08-02 霍夫曼-拉罗奇有限公司 抗-pd-l1抗体及它们用于增强t细胞功能的用途
EP2213682A1 (fr) 2009-01-30 2010-08-04 Institut Curie TSLP favorisant l'évasion immunitaire et la persistance de virus
JP6077856B2 (ja) 2009-11-04 2017-02-08 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 操作型抗ｔｓｌｐ抗体本出願は、米国特許仮出願第６１／２９７，００８号（２０１０年１月２１日出願）、および米国特許仮出願第６１／２５８，０５１号（２００９年１１月４日出願）の利益を主張し、該仮出願は各々、引用によりその全体が本明細書に組み込まれる。

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107980A (ja) * 1995-08-17 1997-04-28 Japan Tobacco Inc 新規生理活性タンパク

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0828003A3 (fr) * 1996-09-06 2003-01-15 SmithKline Beecham plc Sérine protéase humaine
JP2001505783A (ja) * 1996-12-11 2001-05-08 カイロン コーポレイション 分泌ヒトタンパク質

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107980A (ja) * 1995-08-17 1997-04-28 Japan Tobacco Inc 新規生理活性タンパク

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] HILLIER ET AL.: "zx70c12.r1 Soares_total_fetus_Nb2HF8_9w Homo sapiens cDNA clone", XP002235795, retrieved from EBI Database accession no. AA496215 *
PALLEN M J ET AL: "THE HTRA FAMILY OF SERINE PROTEASES", MOLECULAR MICROBIOLOGY, BLACKWELL SCIENTIFIC, OXFORD, GB, vol. 26, no. 2, 1997, pages 209 - 221, XP000946617, ISSN: 0950-382X *
See also references of WO0039149A3 *

Also Published As

Publication number Publication date
EP1140976A2 (fr) 2001-10-10
WO2000039149A2 (fr) 2000-07-06
WO2000039149A3 (fr) 2000-11-16
AU2396600A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
EP1218411A4 (fr) Proteines secretees et leurs utilisations
EP1088071A4 (fr) 94 proteines humaines secretees
EP1100869A4 (fr) 98 proteines humaines secretees
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
HUP0200414A2 (en) Interferon-betha fusion proteins and uses
EP1109821A4 (fr) 49 proteines humaines secretees
EP1078046A4 (fr) 97 proteines humaines secretees
AU2577799A (en) 45 human secreted proteins
EP1140970A4 (fr) 47 proteines humaines secretees
EP1051426A4 (fr) 67 proteines humaines secretees
EP1064297A4 (fr) 95 proteines humaines secretees
EP1044211A4 (fr) 36 proteines humaines secretees
EP1097199A4 (fr) 71 proteines humaines secretees
EP1115735A4 (fr) 31 proteines humaines secretees
EP1124850A4 (fr) 12 proteines humaines secretees
GB9806806D0 (en) Peptides and uses thereof
EP1140976A4 (fr) Proteines secretees et leurs utilisations
EP1062236A4 (fr) 31 proteines humaines secretees
AU6394400A (en) Secreted proteins and uses thereof
EP1073458A4 (fr) Proteines de chlamydia et leurs utilisations
EP1189938A4 (fr) Proteines secretees et utilisations associees
EP1179000A4 (fr) Proteines secretees et leurs utilisations
AU6280999A (en) Novel secreted immunomodulatory proteins and uses thereof
EP1082335A4 (fr) Nouvelles proteines secretees et associees a une membrane et leurs utilisations
EP1056760A4 (fr) Proteines secretees par l'homme

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010704

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 9/64 B

Ipc: 7C 07K 1/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030409

DA4 Supplementary search report drawn up and despatched (deleted)
DA4 Supplementary search report drawn up and despatched (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20030716

17Q First examination report despatched

Effective date: 20031111

17Q First examination report despatched

Effective date: 20031111

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070625